Skip to main content
Toggle navigation
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
J
Jagannath, Sundar
Mount Sinai Medical Center, New York, NY, USA
Plenary Session
Location: Hall FG
Sundar Jagannath
Jakubowiak, Andrzej
The University of Chicago
Abstract Session 3
Location: Room 701
Andrzej Jakubowiak
(OA-51) Carfilzomib, Lenalidomide, and Dexamethasone (KRd) after Autologous Stem-Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: Analysis of High-Risk Subset in Phase 3 ATLAS Trial
Location: Room 701
Andrzej Jakubowiak
Jimenez Zepeda, Victor
Arthur JE Child Comprehensive Cancer Center
Meet the Experts: MGRS - diagnosis and management
Location: Room 716A
Victor Jimenez Zepeda
Joseph, Nisha
Winship Cancer Institute, Emory University
Abstract Session 5
Location: Room 701
Nisha Joseph
Joshua, Douglas
University of Sydney
Abstract Session 5
Location: Room 701
Douglas Joshua
Josic, Maria
Pfizer
(PA-039) Differential Impact of BCMA (TNFRSF17) Extracellular Domain Mutations on in vitro Potency of Elranatamab versus Teclistamab
Location: Room 714A
Maria Josic
Jung, David
University of Calgary
(OA-06) Inactivation of TRAF3 and CYLD Drive Resistance to T-Cell Based Therapies in Multiple Myeloma by Promoting Inflammation and an Immunosuppressive Microenvironment that Impair T Cell Function
Location: Room 718
David Jung
